#United States #Rockville #Medicare #Same-Day Care #American Podiatric Medical Association

APMA Raises Alarm Over CMS's Decision on Same-Day Care

In a recent announcement that has sent ripples through the healthcare community, the American Podiatric Medical Association (APMA) has voiced deep concerns regarding a decision made by the Centers for Medicare and Medicaid Services (CMS). The agency's plan to enact a 20% reduction in payment for certain same-day services beginning on January 1, 2027 is viewed as a significant barrier to patient care.

The New Rule Explained

According to the latest update from CMS, the policy will impact office and outpatient evaluation and management (E/M) visits when billed with modifier 25 alongside a 0-day global procedure. While the highest-paid service in such cases will remain unaffected, other relevant services will face the harsh 20% reduction. This shift particularly targets services provided by the same physician or those within the same specialty group practice.

Although the new reduction marks a slight alleviation from an earlier proposal of a 50% cut, the implications remain grave for practices and their patients. CMS itself has acknowledged that this new structure disproportionately affects podiatry services. The situation is particularly concerning given that podiatrists often address multiple, sometimes life-threatening conditions during a single patient visit, including diabetic foot ulcers.

The APMA's Ongoing Advocacy

Since the proposal's inception, APMA has strongly opposed it—collaborating with the Same Day Care Coalition, which comprises various medical specialties and patient advocacy groups. The association argues that the cuts, coupled with rising operational costs and stagnating payment updates, could lead to practice closures. Smaller practices, particularly those in rural areas, stand to be especially vulnerable, with potential consolidations threatening the very fabric of podiatric care and limiting patient access at critical moments.

Medical professionals emphasize that the CMS policy jeopardizes patients’ abilities to receive crucial foot and ankle care in a single visit. For patients with diabetes, the potential delays in both evaluation and necessary treatment may increase the likelihood of severe complications, including infections and amputations.

Concerns from Healthcare Leaders

Patrick DeHeer, DPM, the President of APMA, expressed shock and concern over CMS's decision to proceed with any payment cuts, given the steady stream of warnings from healthcare professionals across various specialties. “This new policy threatens access to medically necessary same-day care, particularly for patients in rural and underserved communities,” he remarked. “APMA unequivocally condemns cuts that limit or delay essential foot and ankle care, putting seniors' health, mobility, and independence at risk.”

APMA's efforts to express these concerns have not been limited to formal statements alone; they have also reached out directly to CMS, various political figures, and stakeholders in healthcare. Recently, thousands of patients, practicing podiatrists, and students in podiatric medicine have rallied to send petitions and messages to legislators and regulators, urging them to reconsider the impending rule's rollout.

Continuing Efforts and Future Actions

Looking forward, APMA remains committed to working alongside their partners in the Same Day Care Coalition, advocating for Congress to intervene and halt the implementation of this rule. As the nation's leading professional organization for podiatrists—who are exceptionally educated and trained to diagnose and treat foot, ankle, and leg conditions—the APMA stands firm in their position, striving to protect both practices and patients in the field of podiatric medicine.

For further information, the APMA can be reached at their official website www.apma.org or through direct inquiries with their communication team.

Contact Information

Elisabeth Campbell, MPSE
Email: [email protected]
Phone: 301-581-9222

This situation continues to evolve, and APMA is determined to fight for the care that patients require and deserve. The implications of the decision extend beyond financial—threatening both the viability of the podiatric workforce and crucial access to care for patients who need it most.